These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38781783)

  • 1. Polypharmacy, drug-drug interactions, and adverse drug reactions among systemic sclerosis patients: A cross-sectional risk factor study.
    Boukhlal S; Chouchana L; Saadi M; Casadevall M; Cohen P; Dunogue B; Murarasu A; Regent A; Mouthon L; Chaigne B
    Semin Arthritis Rheum; 2024 Aug; 67():152469. PubMed ID: 38781783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence, severity, and nature of risk factors associated with drug-drug interactions in geriatric patients receiving cancer chemotherapy: A prospective study in a tertiary care teaching hospital.
    Ramasubbu SK; Mahato SK; Agnihotri A; Pasricha RK; Nath UK; Das B
    Cancer Treat Res Commun; 2021; 26():100277. PubMed ID: 33348276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug-drug interactions.
    Crescioli G; Brilli V; Lanzi C; Burgalassi A; Ieri A; Bonaiuti R; Romano E; Innocenti R; Mannaioni G; Vannacci A; Lombardi N
    Intern Emerg Med; 2021 Apr; 16(3):697-710. PubMed ID: 33355896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and predictors of adverse drug reactions caused by drug-drug interactions in elderly outpatients: a prospective cohort study.
    Obreli Neto PR; Nobili A; de Lyra DP; Pilger D; Guidoni CM; de Oliveira Baldoni A; Cruciol-Souza JM; de Carvalho Freitas AL; Tettamanti M; Gaeti WP; Nakamura Cuman RK
    J Pharm Pharm Sci; 2012; 15(2):332-43. PubMed ID: 22579011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse Drug Reactions in an Oncological Population: Prevalence, Predictability, and Preventability.
    Lavan AH; O'Mahony D; Buckley M; O'Mahony D; Gallagher P
    Oncologist; 2019 Sep; 24(9):e968-e977. PubMed ID: 30833488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polypharmacy, aging and potential drug-drug interactions in outpatients in Taiwan: a retrospective computerized screening study.
    Lin CF; Wang CY; Bai CH
    Drugs Aging; 2011 Mar; 28(3):219-25. PubMed ID: 21250763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential drug-drug interactions and polypharmacy in institutionalized elderly patients in a public hospital in Brazil.
    Castilho ECD; Reis AMM; Borges TL; Siqueira LDC; Miasso AI
    J Psychiatr Ment Health Nurs; 2018 Feb; 25(1):3-13. PubMed ID: 28892271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse drug reactions caused by drug-drug interactions in elderly outpatients: a prospective cohort study.
    Obreli-Neto PR; Nobili A; de Oliveira Baldoni A; Guidoni CM; de Lyra Júnior DP; Pilger D; Duzanski J; Tettamanti M; Cruciol-Souza JM; Gaeti WP; Cuman RK
    Eur J Clin Pharmacol; 2012 Dec; 68(12):1667-76. PubMed ID: 22644345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying adverse drug reactions associated with drug-drug interactions: data mining of a spontaneous reporting database in Italy.
    Leone R; Magro L; Moretti U; Cutroneo P; Moschini M; Motola D; Tuccori M; Conforti A
    Drug Saf; 2010 Aug; 33(8):667-75. PubMed ID: 20635825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical relevance of drug-drug interactions in hospitalized dermatology patients.
    Ganeva M; Gancheva T; Troeva J; Kiriyak N; Hristakieva E
    Adv Clin Exp Med; 2013; 22(4):555-63. PubMed ID: 23986216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse drug reactions caused by drug-drug interactions in cardiovascular disease patients: introduction of a simple prediction tool using electronic screening database items.
    Kovačević M; Vezmar Kovačević S; Radovanović S; Stevanović P; Miljković B
    Curr Med Res Opin; 2019 Nov; 35(11):1873-1883. PubMed ID: 31328967
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug-drug interactions in a geriatric outpatient cohort: prevalence and relevance.
    Tulner LR; Frankfort SV; Gijsen GJ; van Campen JP; Koks CH; Beijnen JH
    Drugs Aging; 2008; 25(4):343-55. PubMed ID: 18361544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comorbidity, Polytherapy, and Drug Interactions in a Neurological Context: An Example of a Multidisciplinary Approach to Promote the Rational Use of Drugs.
    Busa G; Burlina A; Damuzzo V; Chiumente M; Palozzo AC
    J Pharm Pract; 2018 Feb; 31(1):58-65. PubMed ID: 29278992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Data-driven prediction of adverse drug reactions induced by drug-drug interactions.
    Liu R; AbdulHameed MDM; Kumar K; Yu X; Wallqvist A; Reifman J
    BMC Pharmacol Toxicol; 2017 Jun; 18(1):44. PubMed ID: 28595649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying and Characterizing Serious Adverse Drug Reactions Associated With Drug-Drug Interactions in a Spontaneous Reporting Database.
    Magro L; Arzenton E; Leone R; Stano MG; Vezzaro M; Rudolph A; Castagna I; Moretti U
    Front Pharmacol; 2020; 11():622862. PubMed ID: 33536925
    [No Abstract]   [Full Text] [Related]  

  • 16. A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting.
    Alhawassi TM; Krass I; Bajorek BV; Pont LG
    Clin Interv Aging; 2014; 9():2079-86. PubMed ID: 25489239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous Reports of Serious Adverse Drug Reactions Resulting From Drug-Drug Interactions: An Analysis From the French Pharmacovigilance Database.
    Létinier L; Ferreira A; Marceron A; Babin M; Micallef J; Miremont-Salamé G; Pariente A;
    Front Pharmacol; 2020; 11():624562. PubMed ID: 33841134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actual drug-drug interactions in elderly patients discharged from internal medicine clinic: a prospective observational study.
    Marusic S; Bacic-Vrca V; Obreli Neto PR; Franic M; Erdeljic V; Gojo-Tomic N
    Eur J Clin Pharmacol; 2013 Sep; 69(9):1717-24. PubMed ID: 23739998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy.
    Doan J; Zakrzewski-Jakubiak H; Roy J; Turgeon J; Tannenbaum C
    Ann Pharmacother; 2013 Mar; 47(3):324-32. PubMed ID: 23482734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Potential Drug-Drug Interactions and Association with Adverse Drug Reactions in Predialysis Chronic Kidney Disease Patients at Indonesian National Referral Hospital.
    Khusfiani T; Soetikno V; Hustrini NM; Nafrialdi N
    Acta Med Indones; 2023 Jul; 55(3):277-284. PubMed ID: 37915149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.